Furthermore, irregular insulin injection procedures can increase the incidence of bleeding, pain, subcutaneous fat hyperplasia, and increase the risk of cross-infection, and affect the therapeutic efficacy of patients (18, 19). The gene discussed is INS; the disease is nosocomial infection.